Attached files
| file | filename |
|---|---|
| 10-Q/A - AMENDMENT NO. 1 TO FORM 10-Q - Jazz Pharmaceuticals plc | d394051d10qa.htm |
| EX-10.11 - ROYALTY BEARING LICENSE AGREEMENT AND SUPPLY AGREEMENT - Jazz Pharmaceuticals plc | d394051dex1011.htm |
| EX-31.3 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc | d394051dex313.htm |
Exhibit 31.4
CERTIFICATION
I, Kathryn E. Falberg, certify that:
| 1. | I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q/A of Jazz Pharmaceuticals Public Limited Company; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
| Date: August 9, 2012 | By: | /s/ Kathryn E. Falberg | ||||
| Kathryn E. Falberg Executive Vice President and Chief Financial Officer | ||||||